AAAAAA

   
Results: 1-25 | 26-40
Results: 1-25/40
PHARMACOKINETICS OF LINEZOLID IN SUBJECTS WITH VARYING DEGREES OF RENAL-FUNCTION AND ON DIALYSIS
Authors: BRIER ME STALKER DJ ARONOFF GR BATTS DH RYAN KK OGRADY MA HOPKINS NK
Citation: Me. Brier et al., PHARMACOKINETICS OF LINEZOLID IN SUBJECTS WITH VARYING DEGREES OF RENAL-FUNCTION AND ON DIALYSIS, Journal of investigative medicine, 46(7), 1998, pp. 276-276
QUALITY-OF-LIFE DURING AND BETWEEN HEMODIALYSIS TREATMENTS - ROLE OF L-CARNITINE SUPPLEMENTATION
Authors: SLOAN RS KASTAN B RICE SI SALLEE CW YUENGER NJ SMITH B WARD RA BRIER ME GOLPER TA
Citation: Rs. Sloan et al., QUALITY-OF-LIFE DURING AND BETWEEN HEMODIALYSIS TREATMENTS - ROLE OF L-CARNITINE SUPPLEMENTATION, American journal of kidney diseases, 32(2), 1998, pp. 265-272
CONTINUOUS VENOVENOUS HEMOFILTRATION AND HEMODIALYSIS AFTER ORTHOTOPIC HEART-TRANSPLANTATION
Authors: OUSEPH R BRIER ME JACOBS AA ERBECK KM
Citation: R. Ouseph et al., CONTINUOUS VENOVENOUS HEMOFILTRATION AND HEMODIALYSIS AFTER ORTHOTOPIC HEART-TRANSPLANTATION, American journal of kidney diseases, 32(2), 1998, pp. 290-294
PREDICTION OF ANTICOAGULATION DURING HEMODIALYSIS BY POPULATION-KINETICS AND AN ARTIFICIAL NEURAL-NETWORK
Authors: SMITH BP WARD RA BRIER ME
Citation: Bp. Smith et al., PREDICTION OF ANTICOAGULATION DURING HEMODIALYSIS BY POPULATION-KINETICS AND AN ARTIFICIAL NEURAL-NETWORK, Artificial organs, 22(9), 1998, pp. 731-739
PHARMACOKINETICS OF ORAL GLYBURIDE IN SUBJECTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS AND RENAL-FAILURE
Authors: BRIER ME BAYS H SLOAN R STALKER DJ WELSHMAN I ARONOFF GR
Citation: Me. Brier et al., PHARMACOKINETICS OF ORAL GLYBURIDE IN SUBJECTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS AND RENAL-FAILURE, American journal of kidney diseases, 29(6), 1997, pp. 907-911
OUTCOMES OF SINGLE ORGANISM PERITONITIS IN PERITONEAL-DIALYSIS - GRAM-NEGATIVES VERSUS GRAM-POSITIVES IN THE NETWORK-9 PERITONITIS STUDY
Authors: BUNKE CM BRIER ME GOLPER TA
Citation: Cm. Bunke et al., OUTCOMES OF SINGLE ORGANISM PERITONITIS IN PERITONEAL-DIALYSIS - GRAM-NEGATIVES VERSUS GRAM-POSITIVES IN THE NETWORK-9 PERITONITIS STUDY, Kidney international, 52(2), 1997, pp. 524-529
NONMEM ANALYSIS OF DESTRUCTIVELY OBTAINED TISSUE SAMPLES
Authors: BRIER ME
Citation: Me. Brier, NONMEM ANALYSIS OF DESTRUCTIVELY OBTAINED TISSUE SAMPLES, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 80-80
ADAPTIVE-CONTROL OF HEPARIN USING AN ARTIFICIAL NEURAL-NETWORK
Authors: BRIER ME DEVILLEZ AB
Citation: Me. Brier et Ab. Devillez, ADAPTIVE-CONTROL OF HEPARIN USING AN ARTIFICIAL NEURAL-NETWORK, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 81-81
PREDICTING THE DOSE OF HEPARIN FOR DIALYSIS PATIENTS USING AN ARTIFICIAL NEURAL-NETWORK
Authors: BRIER ME SMITH BP WARD RA
Citation: Me. Brier et al., PREDICTING THE DOSE OF HEPARIN FOR DIALYSIS PATIENTS USING AN ARTIFICIAL NEURAL-NETWORK, Journal of investigative medicine, 44(7), 1996, pp. 343-343
ARTIFICIAL NEURAL NETWORKS PREDICT DRUG DOSE IN RENAL-DISEASE
Authors: BRIER ME ARONOFF GR
Citation: Me. Brier et Gr. Aronoff, ARTIFICIAL NEURAL NETWORKS PREDICT DRUG DOSE IN RENAL-DISEASE, Journal of the American Society of Nephrology, 7(9), 1996, pp. 684-684
PREDICTING THE DOSE OF HEPARIN FOR DIALYSIS PATIENTS USING AN ARTIFICIAL NEURAL-NETWORK
Authors: BRIER ME SMITH BP WARD RA
Citation: Me. Brier et al., PREDICTING THE DOSE OF HEPARIN FOR DIALYSIS PATIENTS USING AN ARTIFICIAL NEURAL-NETWORK, Journal of the American Society of Nephrology, 7(9), 1996, pp. 789-789
THE OUTCOMES OF SINGLE ORGANISM PERITONITIS DIFFER BY PATHOGENS - GRAM NEGATIVES (GN) VS GRAM POSITIVES (GP)
Authors: BUNKE M BRIER ME GOLPER TA
Citation: M. Bunke et al., THE OUTCOMES OF SINGLE ORGANISM PERITONITIS DIFFER BY PATHOGENS - GRAM NEGATIVES (GN) VS GRAM POSITIVES (GP), Journal of the American Society of Nephrology, 7(9), 1996, pp. 964-964
APPLICATION OF ARTIFICIAL NEURAL NETWORKS TO CLINICAL-PHARMACOLOGY
Authors: BRIER ME ARONOFF GR
Citation: Me. Brier et Gr. Aronoff, APPLICATION OF ARTIFICIAL NEURAL NETWORKS TO CLINICAL-PHARMACOLOGY, International journal of clinical pharmacology and therapeutics, 34(11), 1996, pp. 510-514
RISK-FACTORS FOR PERITONITIS IN LONG-TERM PERITONEAL-DIALYSIS - THE NETWORK-9 PERITONITIS AND CATHETER SURVIVAL STUDIES
Authors: GOLPER TA BRIER ME BUNKE M SCHREIBER MJ BARTLETT DK HAMILTON RW STRIFE F HAMBURGER RJ
Citation: Ta. Golper et al., RISK-FACTORS FOR PERITONITIS IN LONG-TERM PERITONEAL-DIALYSIS - THE NETWORK-9 PERITONITIS AND CATHETER SURVIVAL STUDIES, American journal of kidney diseases, 28(3), 1996, pp. 428-436
STATISTICAL APPROACH TO NEURAL-NETWORK MODEL-BUILDING FOR GENTAMICIN PEAK PREDICTIONS
Authors: SMITH BP BRIER ME
Citation: Bp. Smith et Me. Brier, STATISTICAL APPROACH TO NEURAL-NETWORK MODEL-BUILDING FOR GENTAMICIN PEAK PREDICTIONS, Journal of pharmaceutical sciences, 85(1), 1996, pp. 65-69
HEMODYNAMIC, RENAL, AND HORMONAL RESPONSES TO LOWER-BODY POSITIVE PRESSURE IN HUMAN-SUBJECTS
Authors: MANNIX ET FARBER MO ARONOFF GR BRIER ME WEINBERGER MH PALANGE P MANFREDI F
Citation: Et. Mannix et al., HEMODYNAMIC, RENAL, AND HORMONAL RESPONSES TO LOWER-BODY POSITIVE PRESSURE IN HUMAN-SUBJECTS, The Journal of laboratory and clinical medicine, 128(6), 1996, pp. 585-593
COMPARISON OF NEURAL-NETWORK, GENERALIZED LINEAR, AND GENERALIZED ADDITIVE-MODELS
Authors: BRIER ME
Citation: Me. Brier, COMPARISON OF NEURAL-NETWORK, GENERALIZED LINEAR, AND GENERALIZED ADDITIVE-MODELS, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 101-101
THERAPEUTIC DRUG-MONITORING OF GENTAMICIN USING AN ARTIFICIAL NEURAL-NETWORK
Authors: BRIER ME FINGAR B
Citation: Me. Brier et B. Fingar, THERAPEUTIC DRUG-MONITORING OF GENTAMICIN USING AN ARTIFICIAL NEURAL-NETWORK, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 104-104
RENAL REPLACEMENT THERAPY IN ALLOGENEIC VERSUS AUTOLOGOUS BONE-MARROWTRANSPLANTATION
Authors: ERBECK KM JACOBS AA SMITH BA BRIER ME STEVENS DA
Citation: Km. Erbeck et al., RENAL REPLACEMENT THERAPY IN ALLOGENEIC VERSUS AUTOLOGOUS BONE-MARROWTRANSPLANTATION, Journal of the American Society of Nephrology, 6(3), 1995, pp. 462-462
EFFECT OF HEMODIALYSIS ACCESS ON DELIVERED DOSE OF DIALYSIS (KT V)/
Authors: ERBECK KM BRIER ME DEOREO P HAMBURGER R
Citation: Km. Erbeck et al., EFFECT OF HEMODIALYSIS ACCESS ON DELIVERED DOSE OF DIALYSIS (KT V)/, Journal of the American Society of Nephrology, 6(3), 1995, pp. 487-487
PREDICTORS OF SHORT-TERM MORTALITY IN DIABETIC HEMODIALYSIS-PATIENTS
Authors: WARD RA BRIER ME DEOREO P ERBECK KM HAMBURGER RJ SMITH BA
Citation: Ra. Ward et al., PREDICTORS OF SHORT-TERM MORTALITY IN DIABETIC HEMODIALYSIS-PATIENTS, Journal of the American Society of Nephrology, 6(3), 1995, pp. 567-567
PREDICTION OF DELAYED RENAL-ALLOGRAFT FUNCTION USING NEURAL NETWORKS
Authors: BRIER ME KLEIN JB
Citation: Me. Brier et Jb. Klein, PREDICTION OF DELAYED RENAL-ALLOGRAFT FUNCTION USING NEURAL NETWORKS, Journal of the American Society of Nephrology, 6(3), 1995, pp. 1075-1075
RACE MISMATCH CORRELATES WITH DELAYED RENAL-ALLOGRAFT FUNCTION AND SURVIVAL
Authors: KLEIN JB BENTLEY FR BRIER ME
Citation: Jb. Klein et al., RACE MISMATCH CORRELATES WITH DELAYED RENAL-ALLOGRAFT FUNCTION AND SURVIVAL, Journal of the American Society of Nephrology, 6(3), 1995, pp. 1099-1099
NEURAL-NETWORK PREDICTED PEAK AND TROUGH GENTAMICIN CONCENTRATIONS
Authors: BRIER ME ZURADA JM ARONOFF GR
Citation: Me. Brier et al., NEURAL-NETWORK PREDICTED PEAK AND TROUGH GENTAMICIN CONCENTRATIONS, Pharmaceutical research, 12(3), 1995, pp. 406-412
LASER INDIRECT OPHTHALMOSCOPE PHOTOCOAGULATION AND SCLERAL DEPRESSIONFOR RHEGMATOGENOUS RETINAE DETACHMENT
Authors: BLOOM SM MURPHY SF BRIER ME
Citation: Sm. Bloom et al., LASER INDIRECT OPHTHALMOSCOPE PHOTOCOAGULATION AND SCLERAL DEPRESSIONFOR RHEGMATOGENOUS RETINAE DETACHMENT, Retina, 15(3), 1995, pp. 224-232
Risultati: 1-25 | 26-40